🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Grace Therapeutics, Inc.

GRCE Healthcare
$1.73 +$0.01 (0.58%)
Market Cap: $36.39 M
Gurus Holding
1
Popularity Rank
#4640
% of Shares Held
0.88%
Net Activity (Q3 2026)
+$400,188

Guru Ownership Trend

Guru Analysis for Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics, Inc. (GRCE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $322,011.82.

Top institutional holders include Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $400,188 net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$400,188
Total Buy Value
New Buys 1
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Grace Therapeutics, Inc. (GRCE)

Major holders include Renaissance Technologies (RenTech) ($400,188). According to the latest reported data, 1 tracked investment managers collectively hold approximately 186,134 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $400,188, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in GRCE during the most recent reporting period.

Yes, 1 managers opened new positions in GRCE, and 0 increased their existing holdings. The total reported buy value was $400,188.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 186,134 $400,188 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form